E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Add to balance / Manage account  User:  Log out
Prospect News home > News index > List of issuers S > Headlines for Suven Life Sciences Ltd. > News item
Published on 7/29/2009 in the Prospect News Convertibles Daily.

Suven Life Sciences could issue up to $50 million convertible bonds

By Devika Patel

Knoxville, Tenn., July 29 - Suven Life Sciences Ltd. informed the Bombay Stock Exchange that it could raise up to $50 million via foreign-currency convertible bonds. The company approved the proposal at a board meeting on July 28.

Securities also may include Global Depository Receipts, American Depository Receipts and equity shares.

Suven Life Sciences is a Hyderabad, India-based pharmaceutical company.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.